By Blair Childs, Senior Vice President of Public Affairs, Premier
As the Senate explores the next generation of user fee agreements, members of the Premier healthcare alliance remain steadfast in their advocacy for a more nimble and effective FDA. Today, the FDA approval process is too slow, taking up to 3+ years in some cases to approve generic drugs that could save lives and lower prices by creating a more competitive market. Our hope is that with the proper resources, the FDA will be able to clear away this backlog, allowing new competitors to enter the market and providers to gain the benefit of a healthy and competitive marketplace.
-By Blair Childs, Senior Vice President of Public Affairs, Premier Inc.